Watch: Kiran Mazumdar-Shaw on Covaxin getting approval for emergency use for children aged 12

Lockdown 4.0: Is leeway to states right move? Kiran Mazumdar-Shaw shares her perspective

Don't think the budget has moved the needle in improving consumption, says Kiran Mazumdar Shaw of Biocon

स्वदेशी वैक्सीन Covaxin पर बड़ी खबर | Bharat Biotech gets nod to move to phase 2 trials of Covaxin

kiran-mazumdar-shaw-at-global-technology-summit

Q4 Review: Biocon's Kiran Mazumdar Shaw On Earnings & FY23 Projections

Kiran Mazumdar Shaw On Fighting and Recovering From COVID-19: ‘Dont Panic, Be Positive

Interview: Biocon's Chairman MD: Kiran Mazumdar-Shaw

Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook

Safe place to be in if coronavirus mortality rate brought down: Kiran Mazumdar Shaw

Kiran Mazumdar-Shaw on why India needs to open up after May 3rd 

Kiran Mazumdar-Shaw | Compassionate capitalism

Kiran Mazumdar-Shaw | Entrepreneurship made me aware of social needs

Kiran Mazumdar-Shaw | Certain investments should be considered philanthropic

Look forward to an IPO in next 18-24 months, says Biocon’s Kiran Mazumdar Shaw

Kiran Mazumdar Shaw Backs Sikka & Team

Kiran Mazumdar Shaw: The entrepreneur ahead of her time

Shah Rukh Khan calls Kiran Mazumdar Shaw a role model (GOSSIP)

Kiran Mazumdar-Shaw | Advice to new philanthropists: where can you make a difference?

Kiran Mazumdar-Shaw | Philanthropic focus on research

Digvijaya Singh in race for Congress president post

Priyank Sharma, Dhanashree Verma share memories of Maine Payal Hai Chhankai, working with Neha Kakkar | Exclusive

Ashok Gehlot reaches Delhi to meet Congress leader Sonia Gandhi

After sweeping pan-India raids, Centre bans radical outfit PFI over alleged terror funding; more

Assam CM welcomes ban on PFI, says radicals will be dealt with iron fist; more

PFI, 8 associated fronts now declared 'unlawful organisations'; Congress demands RSS ban; more

Biocon and HealthCare Global In Focus | Earnings Edge | NDTV Profit

Q1 Review: Biocon's Profit, Margins Fall; Misses Estimates

Q4 Review | Biocon March Quarter Net Profit Soars

Stocks In Focus: Biocon, CG Power and Industrials, LIC & More

Q2 Review: After Weak Q2, Can Biocon Bounce Back In Q3? | BQPrime

Biocon Withdraws Drug Application With EMA